Previous Article | Next Article ![]()
Journal of Bacteriology, May 2009, p. 3003-3010, Vol. 191, No. 9
0021-9193/09/$08.00+0 doi:10.1128/JB.01694-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Jeffrey A. Pearl,
and
Christopher V. Rao*
Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801
Received 4 December 2008/ Accepted 6 February 2009
|
|
|---|
|
|
|---|
Type I fimbriation is environmentally regulated with fim gene expression favored in static liquid medium, whereas growth on solid medium inhibits expression (17). Moreover, serovar Typhimurium cultures in fimbriae-inducing conditions contain cells in both fimbriated and nonfimbriated states (35). While the regulation of fim gene expression has been studied extensively in Escherichia coli, far less is known about the regulation in serovar Typhimurium (1, 27). In particular, despite homology between the structural genes for type I fimbriae in E. coli and serovar Typhimurium, their expression is regulated in completely different manners. No homologs of E. coli regulators, FimB and FimE, are present in serovar Typhimurium (24, 28). Also, the serovar Typhimurium PfimA promoter is inactive in E. coli, indicating that the PfimA promoter is regulated by different factors in these two organisms (48). In serovar Typhimurium, the expression of the structural genes is regulated by three transcription factors, FimY, FimZ, and FimW (44, 46, 48). Both FimZ and FimY are essential for the expression of the structural genes from the PfimA promoter (48). In particular, the deletion of either the fimY or fimZ gene reduces expression from the PfimA promoter and prevents serovar Typhimurium from making type I fimbriae. FimZ has been shown to bind the PfimA promoter and promote transcription (13, 48). FimY, on the other hand, is thought to facilitate the activation of the PfimA promoter, as direct binding has not been observed (44). FimW is a negative regulator of fim gene expression (45). FimW has also been suggested to autoregulate its expression, as enhanced PfimW activity has been observed in the
fimW mutant. In DNA-binding assays, FimW was not observed to bind any of the fim promoters. However, FimW was found to interact with FimZ in a LexA-based two-hybrid system in E. coli (45). Thus, a possible mechanism for FimW-mediated repression may be that it binds FimZ and prevents it from activating transcription. However, an analysis of the FimW amino acid sequence predicts that it has a DNA-binding domain. Moreover, it is related to a broad range of prokaryotic transcription factors, with its closest relatives being BpdT from Rhodococcus spp. and an uncharacterized response regulator, TodD, from Pseudomonas putida (29, 30). Thus, FimW may also act by an alternate mechanism involving DNA binding.
In addition to these transcription factors, the fimU tRNA also plays a role in fim gene expression (42). All three regulators—FimZ, FimY, and FimW—contain a number of the rare arginine codons, AGA and AGG, recognized by the fimU tRNA. In the case of FimY,
fimU mutants have been shown to be nonfimbriated due to the inefficient translation of fimY mRNA. This translational regulation results from FimY having three rare arginine codons within its first 14 amino acids. The phenotypic effect of the
fimU mutation could, however, be overcome by expressing fimU from a plasmid or by changing these three rare arginine codons in fimY to ones more efficiently translated.
As a pathogen, serovar Typhimurium invades host cells by a process in which effector proteins are injected into the target cells with the help of the Salmonella pathogenicity island 1 (SPI1) type III secretion system (12, 14). SPI1 gene expression is regulated by a number of proteins, with the critical activator being HilA (2). The expression of hilA, in turn, is regulated by three AraC-like transcriptional activators, hilC, hilD, and rtsA (19, 21, 22, 32, 40, 41). HilD activity is controlled by HilE; this protein binds HilD and is thought to prevent it from activating the PhilA promoter (6, 8). FimY and FimZ have been previously shown to regulate SPI1 gene expression by repressing hilA expression through their activation of the PhilE promoter (7).
In this work, we investigated the gene circuit regulating fim expression. Using genetic approaches, we found that FimZ and FimY activate each other's expression and that each protein can independently activate the PfimA promoter. Moreover, FimZ and FimY were found to be weak autoactivators. Our data also suggest that FimW-mediated repression occurs at the level of fimY transcription. With regard to fimU, we found that none of the fim regulatory genes had any effect on its transcription. As the fim gene circuit involves a combination of positive and negative feedback, we tested whether induction was bistable. However, we found the cell population responded homogeneously when induced. Finally, we looked at the link between the fim and SPI1 gene circuits and found that the PhilE promoter is activated solely by FimZ. Collectively, these results allow us to propose an integrated model for the regulation of the fim gene circuit in serovar Typhimurium.
|
|
|---|
attB sites of the serovar Typhimurium and E. coli genomes were done using the helper plasmid pInt-ts as described previously (25). The loss of the helper plasmid pInt-ts was obtained by growth at 42°C under nonselective conditions. Primers were purchased from IDT, Inc. Enzymes were purchased from New England Biolabs and Fermentas and used according to the manufacturer's recommendations. Strain and plasmid construction. All bacterial strains and plasmids used in this study are described in Tables 1 and 2, respectively. All serovar Typhimurium strains are isogenic derivatives of strain 14028 (American Type Culture Collection [ATCC]). The generalized transducing phage of serovar Typhimurium P22 HT105/1int-201 was used in all transductional crosses (16).
|
View this table: [in a new window] |
TABLE 1. Strains used during this study
|
|
View this table: [in a new window] |
TABLE 2. Plasmids used during this study
|
fimYZ mutant was made using primers SS105F and SS105R. The
fimZ mutant was made using primers SS105FII and SS105F. The
fimY mutant was made using the primers SS105RII and SS105R. The
fimW mutant was made using primers SS152F and SS152R. The
fimU mutant was made using the primers SS165F and SS165R. All mutations were checked by PCR using primers that bound outside the deleted region. Prior to the removal of the antibiotic resistance marker, the constructs resulting from this procedure were moved into a clean wild-type background (14028) by P22 transduction.
In order to construct the fluorescent Venus reporter plasmid (34), PCR was used to amplify Venus from pBS7 using primers LC294F and LC296R. The resulting PCR product was used as a template with primers LC295F and LC296R to add three out-of-frame stop codons and a synthetic Shine-Dalgarno sequence before the Venus start codon. The resultant PCR product was then digested with EcoRI and HindIII and subcloned into the EcoRI and HindIII cut sites of pQE80L (Qiagen), yielding pQE80L-Venus. The plasmid pQE80L was digested with EcoRI and NheI, and the fragment was cloned into the conditional-replication, integration, and modular (CRIM) plasmid pAH125 digested with EcoRI and NheI (25). The resulting CRIM plasmid was called pVenus. Venus transcriptional fusions were made by amplifying the promoter of interest and then cloning these PCR fragments into the multiple cloning site of pVenus. The fimA transcriptional fusion was made using primers SS104F and SS104R. The fimY transcriptional fusion was made using primers SS037F and SS037R. The fimZ transcriptional fusion was made using primers SS103F and SS103R. The fimW transcriptional fusion was made using primers SS154F and SS154R. The fimU transcriptional fusion was made using primers SS162F and SS162R. The hilE transcriptional fusion was made using primers SS024F and SS024R. The PCR fragments were then digested with KpnI and EcoRI (sequences underlined) and cloned into the multiple cloning site of the pVenus vector. The resulting transcriptional fusions were integrated into the serovar Typhimurium and E. coli chromosomes at the
attB site using
Int produced from the CRIM helper plasmid pInt-ts, thus creating single-copy transcriptional fusions. In the case of serovar Typhimurium, the integrated plasmid was moved into different mutant strains by P22 transduction.
Expression plasmids for fimY, fimZ, and fimW were made by cloning the respective gene into the multiple cloning site of pPROTet.E (Clontech) under the control of a strong promoter, PLTetO-1, resulting in plasmids pFimY, pFimZ, and pFimW (33). The plasmid pFimZ was made first by amplifying the fimZ gene using the primers SS106F and SS106R. The PCR product was then digested with EcoRI and KpnI and cloned into pPROTet.E. The plasmid pFimY was made by amplifying the fimY gene using the primers SS107F and SS107R. The PCR product was then digested with SalI and BamHI and cloned into pPROTet.E. The plasmid pFimW was made by amplifying the fimW gene using the primers SS160F and SS160R. The PCR product was then digested with EcoRI and HindIII and cloned into pPROTet.E. In order to mutate the first three arginine rare codons at positions 7, 9, and 14 in fimY, primers SS162F and SS107R were used to amplify fimY with the rare arginine codons mutated to consensus arginine codons. The resulting PCR product was used as a template with primers SS167F and SS107R. The amplified product was digested with EcoRI and BamHI and cloned into the multiple cloning site of pPROTet.E. The plasmid is called pFimY*.
In our expression plasmids, in the absence of TetR, the PLTetO-1 promoter is constitutively active. To regulate the expression levels from the PLTetO-1 promoter, the tetR gene was also cloned downstream of the gene target into the plasmids as previously described (39). In this arrangement, in the absence of the inducer anhydrotetracycline (aTc), expression from the promoter is inhibited due to TetR. The inhibition, however, is relieved upon the addition of 100 ng/ml of aTc, and expression from the PLTetO-1 promoter then takes place. All constructs were sequenced prior to transforming into the wild-type and mutant strains. The sequences for all the primers used in this study are given in Table 3.
|
View this table: [in a new window] |
TABLE 3. List of primers used in the study
|
Single-cell measurements were done similarly by growing the cells in noninducing conditions with vigorous shaking at 37°C. Overnight cultures were subcultured to an OD of 0.05 in fresh medium (LB) and grown in inducing conditions of high oxygen and no shaking at 37°C. Samples were collected at different time points by spinning the cells down, resuspending them in phosphate-buffered saline supplemented with chloramphenicol (34 µg/ml) to stop all translation and arrest the cells in their respective state, and finally storing on ice. All flow cytometry experiments were performed on a BD LRS II system (BD Biosciences). The data extraction and analysis for the flow cytometry experiments were done using FCS Express version 3 (De Novo Software).
|
|
|---|
fimZ,
fimY,
fimYZ, and
fimW mutants (Fig. 1). Chromosomally integrated Venus transcriptional reporters were employed as indirect measures of promoter activities (34). In the cases of all four promoters, activity levels were found to be about two times less active in the
fimZ,
fimY, and
fimYZ mutants than in the wild type. For all four promoters, note that no further reduction in promoter activity was observed in the double mutant. In a
fimW mutant, the activities of all four promoters were approximately two times higher than the wild-type levels. While these results agree with previously published data regarding the fim system in serovar Typhimurium, they still do not tell us how FimW, FimY, and FimZ individually contribute to PfimA activation.
![]() View larger version (18K): [in a new window] |
FIG. 1. FimY and FimZ are activators and FimW is a repressor of fim gene expression. Shown is a comparison of the PfimA, PfimY, PfimZ, and PfimW promoter activities in the wild type and the fimY, fimZ, fimYZ, and fimW mutants. Data are averages of the results from three experiments. Each experiment was done in triplicate.
|
fimYZ mutant in which either FimZ or FimY was expressed from a strong, aTc-inducible promoter on a plasmid (see Materials and Methods). Using this system, we found that expressing FimZ in the
fimYZ mutant led to a more than 10-fold increase in PfimY activity (Fig. 2A). Likewise, expressing FimY in the
fimYZ mutant led to about a 10-fold increase in PfimZ levels. In addition to their ability to activate each other's promoters, FimY and FimZ were found to increase expression from their own promoters roughly threefold.
![]() View larger version (12K): [in a new window] |
FIG. 2. FimY and FimZ are strong activators of each other's expression and also weak autoactivators. Shown is a comparison of the PfimY and PfimZ promoter activities in a serovar Typhimurium fimYZ mutant (A) and E. coli (B) in which FimY and FimZ are independently expressed from an aTc-inducible promoter on a plasmid. Note that tetR is also expressed from this plasmid in order to achieve aTc-inducible expression. Data are averages of the results from three experiments. Each experiment was done in triplicate.
|
FimZ and FimY can independently activate expression from the PfimA promoter.
Next, we looked at how FimZ and FimY independently affected PfimA expression. To investigate this problem, we measured PfimA promoter activity in a
fimYZ mutant in which either FimY or FimZ was expressed using the aTc-inducible system. FimZ expression was found to strongly (>15-fold) activate the PfimA promoter, whereas FimY could only weakly (more than twofold) activate it (Fig. 3). We also performed these experiments with E. coli with similar results (data not shown). Based on these results, we conclude that FimZ and FimY can both independently activate the PfimA promoter. In the case of FimY, the weak activation of the PfimA promoter is likely due to its strong dependence on fimU tRNA (see below) (42).
![]() View larger version (11K): [in a new window] |
FIG. 3. FimY and FimZ can independently activate expression from the PfimA promoter. Shown is a comparison of PfimA promoter activities in a fimYZ mutant in which FimY and FimZ are independently expressed from an aTc-inducible promoter on a plasmid. Data are averages of the results from three experiments. Each experiment was done in triplicate.
|
fimW mutant (Fig. 1). To understand the mechanism of FimW-mediated repression, we first sought to identify the proteins that regulate expression from the PfimW promoter. To answer this question, we measured the level of expression from the PfimW promoter in a
fimYZ mutant in which FimW, FimY, and FimZ were independently expressed using the aTc-inducible system. In the case of FimW and FimZ, expression had no effect on PfimW promoter activity (data not shown). However, in the case of FimY, we observed a significant increase in PfimW promoter activity (1,052 ± 381 relative fluorescence units [RFU]/OD [uninduced] versus 14,718 ± 1,032 RFU/OD [induced]). Similar results were also obtained when these experiments were performed with E. coli (data not shown). To identify the regulatory targets of FimW, we measured the expression of the PfimA, PfimZ, and PfimY promoters in a
fimW
fimYZ mutant in which FimW was expressed using the aTc-inducible system. In the cases of the PfimA and PfimZ promoters, we found that FimW expression had no effect. However, in the case of the PfimY promoter, FimW expression led to about a threefold decrease in PfimY activity (7,462 ± 319 RFU/OD [uninduced] versus 2,781 ± 188 RFU/OD [induced]). Based on these results, we conclude that FimY activates expression from the PfimW promoter and that FimW represses expression from the PfimY promoter.
The PfimU promoter is not regulated by FimW, FimY, or FimZ.
Both fimY and fimZ contain rare arginine codons (AGA and AGG) and need fimU, a tRNA specific for rare arginine codons, for effective translation. In a
fimU mutant, PfimA activity was less than 10-fold compared to the wild-type levels (wild type, 16,723 ± 1,173 RFU/OD; the
fimU mutant, 1,389 ± 261 RFU/OD). The expression of FimY in the
fimU mutant using the aTc-inducible system, however, did not increase PfimA activity (988 ± 319 [uninduced] versus 1,343 ± 166 [induced]). Replacing the rare arginine codons in the fimY gene with consensus ones did restore PfimA activity to the wild-type levels (817 ± 73 RFU/OD [uninduced] versus 11,294 ± 462 RFU/OD [induced]). These experiments are consistent with previously published results (45) and indicate that fimU is essential for effective fimY translation.
As fimU has a strong effect on PfimA promoter activity, we hypothesized that it may be subject to regulation by the other proteins within the circuit. To test this hypothesis, we measured PfimU promoter activity in different regulatory mutants. Contrary to our hypothesis, we did not observe any change in PfimU promoter activity in any mutant (wild type, 26,717 ± 1,381 RFU/OD; the
fimZ mutant, 28,991 ± 2,164 RFU/OD; the
fimY mutant, 25,884 ± 1,983 RFU/OD; the
fimYZ mutant, 26,516 ± 1,772 RFU/OD; and the
fimW mutant, 24,829 ± 2,073 RFU/OD). Likewise, we did not observe any change in PfimU promoter activity when FimW, FimY, and FimZ were expressed using the aTc-inducible system in wild-type serovar Typhimurium or E. coli (data not shown). Based on these results, we conclude that the PfimU promoter is not regulated by any fim protein.
FimZ alone is able to regulate SPI1 gene expression.
Previous studies have shown that both FimY and FimZ regulate SPI1 expression through their activation of the PhilE promoter (7). HilE, in turn, is known to bind HilD and repress the HilD-mediated activation of the PhilA, PhilC, PrtsA, and PhilD promoters (6, 20). To test which protein activates the PhilE promoter, we independently expressed FimY and FimZ in a
fimYZ mutant using the aTc-inducible system and then measured the level of expression from the PhilE promoter. Of the two, only FimZ was found to affect PhilE expression (1,089 ± 421 RFU/OD [uninduced] versus 17,654 ± 2,234 RFU/OD [induced]). Similar results were also observed for E. coli (data not shown).
We note that these results are contrary to those previously reported, for which it was shown that both FimY and FimZ were necessary for activation of the PhilE promoter (7). One possible explanation for the discrepancy involves how the two gene products were selectively expressed. In the original study, a DNA fragment containing the fimYZ gene cluster was cloned onto a plasmid and expressed using the tetracycline promoter. To study their relative effects, each gene was selectively inactivated using a universal translational terminator. As part of the PfimY promoter and the whole PfimZ promoter were left intact in their construct, transcriptional inference may have occurred between the various promoters. In our design, we selectively cloned each gene and then expressed it from an inducible promoter, eliminating any potential interfering effects from having the native promoters still present.
Dynamics of fim gene expression.
Finally, we wished to investigate the dynamics of fim gene expression. We first measured PfimA promoter activity in the wild type and the
fimY,
fimZ,
fimYZ, and
fimW mutants using a microplate reader (Fig. 4A). Consistent with our end-point measurements, we found that the PfimA promoter was weakly expressed in the
fimY,
fimZ, and
fimYZ mutants. Likewise, expression was enhanced in a
fimW mutant. Note that the microplate experiments tell us only about the average response of the population and nothing about how individual cells are behaving. To test whether the cells were responding homogeneously, we also performed single-cell measurements of PfimA promoter activity at selected times in the wild type and a
fimW mutant using flow cytometry (Fig. 4B). Our results indicate that individual wild-type and
fimW mutant cells are responding homogeneously with respect to PfimA promoter activity at all times tested. In other words, we did not observe any phase variation or heterogeneity with regard to PfimA promoter activity in our kinetic experiments.
![]() View larger version (20K): [in a new window] |
FIG. 4. Dynamics of PfimA promoter activity. (A) Population average PfimA activity as a function of time in the wild type and the fimY, fimZ, fimYZ, and fimW mutants. Data are averages of the results from a single experiment with an average of six independent cultures. The experiment was repeated thrice, and identical results were observed. (B) Histogram of single-cell PfimA promoter activity at selected times in the wild type and a fimW mutant. Single-cell measurements of promoter activity were obtained using flow cytometry. Population distribution data are from a single experiment. The experiment was repeated thrice, and identical results were observed (data not shown).
|
|
|
|---|
![]() View larger version (13K): [in a new window] |
FIG. 5. Model for the type I fimbria gene circuit in serovar Typhimurium.
|
While our model for the fim circuit explains internal regulation, it still does not explain how the circuit is activated. In particular, we do not know which factors induce the PfimY and PfimZ promoters. We suspect that these factors activate both promoters, as each alone exhibits some activity in a
fimYZ mutant (Fig. 1). In addition to these factors, another open question concerns whether fimU plays a role in regulating circuit dynamics. While it is tempting to speculate that fimU expression is tuned in response to environmental signals and thus affects circuit dynamics, more likely this gene is constitutively expressed like other tRNAs.
Our results also indicate that the FimW-mediated inhibition of fim gene expression is through repression of the PfimY promoter. Earlier reports suggested that FimW binds FimZ and somehow inhibits the FimZ-dependent activation of fim promoters (45). Moreover, FimW was not found to bind to the PfimW promoter. Based on these results, FimW would appear to repress the PfimY promoter by preventing FimZ from activating it. However, we found that FimW is able to repress the PfimY promoter in the absence of FimZ. Our results would suggest that FimW directly binds the PfimY promoter and represses transcription independently of FimZ. Consistent with our model, FimW has a C-terminal LuxR-type helix-turn-helix DNA domain (SM00421) (31). However, at this time we have no direct experimental support for such a mechanism. Moreover, an equally likely hypothesis is that repression by FimW is indirect. Further experiments are clearly required to determine the mechanism of FimW-mediated repression and distinguish between these different putative models.
A final unanswered question concerns the role of the positive and negative feedback loops in the fim gene circuit. Our initial hypothesis was that these feedback loops would result in bistability. In particular, interacting positive and negative feedback loops are known to be sufficient ingredients for bistability (23). This bistability could potentially explain the phase variation observed in type I fimbriation during growth in inducing conditions (35). To test whether the fim circuit exhibited bistability, we measured PfimA activity at single-cell resolution as a function of time. Contrary to our initial hypothesis, we did not observe a heterogeneous or switch-like response in induction, the telltale indicator of bistability. Rather, we observed a continuous or rheostat-like response in both the wild type and a
fimW mutant (3). One possibility is that there is a lack of correlation between fim gene expression and the production of type I fimbria in serovar Typhimurium (11). Another is that the environment may dictate the response characteristics. For example, under conditions different from those used in our study, Duguid and coworkers observed subpopulations of cells expressing type I fimbriae, indicative of phase variation (17). With these in mind, we hypothesize that the bacteria exhibit type I fimbria phase variation under specific environmental conditions and that the regulation of this process involves posttranscriptional mechanisms as well.
This work was partially supported by grants from the National Science Foundation and the National Institutes of Health.
Published ahead of print on 13 February 2009. ![]()
These authors contributed equally to this work. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»